INDP Sells 20M Shares
Indaptus Therapeutics enters stock sale agreement to sell 20M shares for $0.06/share, expecting $12M in gross proceeds
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.